JP7764992B2 - 大豆ペプチド及び/又はコラーゲンペプチド含有神経心理学的機能改善剤 - Google Patents
大豆ペプチド及び/又はコラーゲンペプチド含有神経心理学的機能改善剤Info
- Publication number
- JP7764992B2 JP7764992B2 JP2021558343A JP2021558343A JP7764992B2 JP 7764992 B2 JP7764992 B2 JP 7764992B2 JP 2021558343 A JP2021558343 A JP 2021558343A JP 2021558343 A JP2021558343 A JP 2021558343A JP 7764992 B2 JP7764992 B2 JP 7764992B2
- Authority
- JP
- Japan
- Prior art keywords
- proline
- peptide
- neuropsychological
- neuropsychological function
- collagen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Food Science & Technology (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019208777 | 2019-11-19 | ||
| JP2019208777 | 2019-11-19 | ||
| PCT/JP2020/042317 WO2021100614A1 (ja) | 2019-11-19 | 2020-11-12 | 大豆ペプチド及び/又はコラーゲンペプチド含有神経心理学的機能改善剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2021100614A1 JPWO2021100614A1 (cg-RX-API-DMAC7.html) | 2021-05-27 |
| JPWO2021100614A5 JPWO2021100614A5 (cg-RX-API-DMAC7.html) | 2022-07-19 |
| JP7764992B2 true JP7764992B2 (ja) | 2025-11-06 |
Family
ID=75981290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021558343A Active JP7764992B2 (ja) | 2019-11-19 | 2020-11-12 | 大豆ペプチド及び/又はコラーゲンペプチド含有神経心理学的機能改善剤 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7764992B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021100614A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022168413A1 (ja) * | 2021-02-04 | 2022-08-11 | ユーハ味覚糖株式会社 | デプレスタチン含有組成物の製造方法 |
| US20250059233A1 (en) * | 2021-12-15 | 2025-02-20 | Viage Therapeutics Inc. | Use of therapeutic peptides |
| JPWO2024117210A1 (cg-RX-API-DMAC7.html) * | 2022-12-01 | 2024-06-06 | ||
| WO2024259556A1 (en) * | 2023-06-19 | 2024-12-26 | Viage Therapeutics, Inc. | Uses of therapeutic peptides |
| EP4743102A1 (en) * | 2024-04-15 | 2026-05-20 | Rousselot BV | Collagen Peptide Composition and its Use in Reversing Neurological Disorders and Fibrosis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010104364A (ja) | 2009-09-18 | 2010-05-13 | Uha Mikakuto Co Ltd | 神経新生促進剤を含有する飲食品 |
| JP2011111440A (ja) | 2009-11-30 | 2011-06-09 | Uha Mikakuto Co Ltd | 神経細胞分化促進剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101415724B (zh) * | 2003-06-30 | 2015-12-02 | 特拉维夫大学未来科技开发有限公司 | 肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法 |
| BRPI0812768A2 (pt) * | 2007-06-08 | 2014-12-02 | Massachusetts Inst Technology | Igf para o tratamento de síndrome de rett e transtornos sinápticos. |
-
2020
- 2020-11-12 WO PCT/JP2020/042317 patent/WO2021100614A1/ja not_active Ceased
- 2020-11-12 JP JP2021558343A patent/JP7764992B2/ja active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010104364A (ja) | 2009-09-18 | 2010-05-13 | Uha Mikakuto Co Ltd | 神経新生促進剤を含有する飲食品 |
| JP2011111440A (ja) | 2009-11-30 | 2011-06-09 | Uha Mikakuto Co Ltd | 神経細胞分化促進剤 |
Non-Patent Citations (6)
| Title |
|---|
| KATAYAMA, S. et al.,Oral Administration of Soy Peptides Suppresses Cognitive Decline by Induction of Neurotrophic Factor,J. Agric. Food Chem.,2014年,62,p.3563-3569 |
| MIZUSHIGE, T.,Ginger-Degraded Collagen Hydrolysate Exhibits Antidepressant Activity in Mice,J. Nutr. Sci. Vitaminol.,2019年06月30日,65 (3),p.251-257 |
| MORI, Y. et al.,Characterization of soy-deprestatin, a novel orally active decapeptide that exerts antidepressant-l,FASEB J.,2018年,32,p.568-575 |
| PEI, X. et al.,Marine collagen peptide isolated from Chum Salmon (Oncorhynchus keta) skin facilitates learning and,Food Chemistry,2010年,118,p.333-340 |
| 永井研迅 ほか,コラーゲンペプチドPro-Hypの抗うつ作用,第71回日本栄養・食糧学会大会講演要旨集,2017年,p.207, 2A-B40 |
| 鹿島康浩 ほか,大豆由来ペプチド配合チュアブル錠が飲用者に与える心理的および生理的な影響評価について ―ランダム化プ,Jpn. Pharmacol. Ther.(薬理と治療),2019年09月20日,47 (9),p.1425-1431 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2021100614A1 (cg-RX-API-DMAC7.html) | 2021-05-27 |
| WO2021100614A1 (ja) | 2021-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2021100614A1 (ja) | 大豆ペプチド及び/又はコラーゲンペプチド含有神経心理学的機能改善剤 | |
| JP6189994B2 (ja) | ジペプチジルペプチダーゼ−iv阻害用飲食品組成物 | |
| JP6344796B2 (ja) | 高齢者用アルツハイマー型認知症改善剤 | |
| WO2003044044A1 (en) | Novel peptide having angiotensin convertase inhibitory effect | |
| JP5976004B2 (ja) | ジペプチジルペプチダーゼ−iv阻害剤 | |
| JP7358239B2 (ja) | エネルギー消費促進用組成物 | |
| JP5972235B2 (ja) | 血中トリグリセライド低下剤 | |
| JP2001031586A (ja) | 動脈硬化症及び動脈硬化症に起因する疾患の予防又は治療組成物 | |
| JP7856910B2 (ja) | 神経心理学的機能改善剤 | |
| JP7787424B2 (ja) | デプレスタチン含有組成物の製造方法 | |
| CN101909645A (zh) | 包含ipp和/或vpp的降血压组合 | |
| JP2000312567A (ja) | 生理活性健康食品 | |
| JP7144441B2 (ja) | 抗酸化及び抗高血圧効果を有するヒラメ練肉及びその製造方法 | |
| JP2013184962A (ja) | ジペプチジルペプチダーゼ−iv阻害剤 | |
| CN101795704B (zh) | 经口组合物 | |
| JP6083085B2 (ja) | アンジオテンシン変換酵素阻害剤およびその用途 | |
| JP5382633B2 (ja) | 脳血管性認知症の予防または治療薬 | |
| JP2001026753A (ja) | 高血圧症予防又は治療用組成物 | |
| JP6589011B2 (ja) | 脳機能障害改善用経口組成物 | |
| JP6243777B2 (ja) | ヒアルロン酸合成促進剤 | |
| JP2020152648A (ja) | 交感神経活性化用組成物 | |
| JP2020097535A (ja) | 血圧を降下させるための組成物 | |
| JP2005239686A (ja) | 脂肪燃焼促進組成物及び該組成物を含有する食品又は医薬品 | |
| JP2005255670A (ja) | ローヤルゼリー由来の降圧ペプチド | |
| JP2024151925A (ja) | 脳内抗酸化酵素活性化組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A527 Effective date: 20220509 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220524 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230830 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240820 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20241021 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20241126 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20250304 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250603 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20250603 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250916 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20251008 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7764992 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |